Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
Accurately determining a company’s long-term prospects isn’t easy, especially when sentiment is weak. That’s where StockStory comes in - to help you find attractive investment candidates backed by unbiased research. Keeping that in mind, here are two stocks poised to prove Wall Street wrong and one where the outlook is warranted.
One stock to sell:
BJ's (BJ)
Consensus price target: $104.80 (-1.5% implied return)
Appealing to the budget-conscious individual shopping for a household, BJ’s Wholesale Club (NYSE: BJ) is a membership-only retail chain that sells groceries, appliances, electronics, and household items, often in bulk quantities.
Why Are We Cautious About BJ?
- The company has faced growth challenges as its 5.5% annual revenue increases over the last three years fell short of other consumer retail companies
- Commoditized inventory, bad unit economics, and high competition are reflected in its low gross margin of 18.4%
- Poor expense management has led to an operating margin of 3.9% that is below the industry average
BJ’s stock price of $106.35 implies a valuation ratio of 21.8x forward P/E. Read our free research report to see why you should think twice about including BJ in your portfolio.
Two stocks to buy:
Intuitive Surgical (ISRG)
Consensus price target: $482.63 (7.4% implied return)
Pioneering minimally invasive surgery since its first da Vinci system was FDA-cleared in 2000, Intuitive Surgical (NASDAQ: ISRG) develops and manufactures robotic-assisted surgical systems that enable minimally invasive procedures across various medical specialties.
Why Should You Buy ISRG?
- Annual revenue growth of 21.3% over the last two years was superb and indicates its market share increased during this cycle
- Share repurchases have amplified shareholder returns as its annual earnings per share growth of 17.4% exceeded its revenue gains over the last five years
- Free cash flow margin grew by 13.5 percentage points over the last five years, giving the company more chips to play with
At $449.25 per share, Intuitive Surgical trades at 37.5x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free.
APA Corporation (APA)
Consensus price target: $49 (-4.9% implied return)
Operating in three continents with a history stretching back to 1954, APA Corporation (NASDAQ: APA) explores for, develops, and produces crude oil, natural gas, and natural gas liquids in the U.S., Egypt, and the U.K. North Sea.
Why Will APA Beat the Market?
- Solid 4.9% annual revenue growth over the last ten years indicates its offerings solve complex business issues
- Massive revenue base of $8.37 billion makes it a household name that influences purchasing decisions
- Highly-profitable operating model results in strong unit economics and a stellar gross margin of 67.7%
APA Corporation is trading at $51.54 per share, or 8.3x forward P/E. Is now a good time to buy? See for yourself in our in-depth research report, it’s free.
Stocks we like even more
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.
